Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctiontranscription coregulator activity

ARID1A MED15 TOB1 NCOA6

8.90e-0656264GO:0003712
GeneOntologyMolecularFunctionATP-dependent chromatin remodeler activity

ARID1A ATRX

4.99e-053762GO:0140658
GeneOntologyMolecularFunctionprotein-macromolecule adaptor activity

ARID1A MED15 TOB1 NCOA6

1.55e-04116064GO:0030674
GeneOntologyMolecularFunctionmolecular adaptor activity

ARID1A MED15 TOB1 NCOA6

2.84e-04135664GO:0060090
GeneOntologyMolecularFunctionATP-dependent activity, acting on DNA

ARID1A ATRX

5.92e-0412762GO:0008094
GeneOntologyMolecularFunctionchromatin binding

ARID1A ATRX NCOA6

9.29e-0473963GO:0003682
GeneOntologyMolecularFunctionnuclear receptor binding

ARID1A NCOA6

1.28e-0318762GO:0016922
GeneOntologyMolecularFunctioncatalytic activity, acting on DNA

ARID1A ATRX

2.48e-0326262GO:0140097
GeneOntologyMolecularFunctiontranscription coactivator activity

ARID1A NCOA6

3.31e-0330362GO:0003713
GeneOntologyMolecularFunctionRNA polymerase II-specific DNA-binding transcription factor binding

ARID1A NCOA6

6.17e-0341762GO:0061629
GeneOntologyMolecularFunctionDNA-binding transcription factor binding

ARID1A NCOA6

1.18e-0258262GO:0140297
GeneOntologyMolecularFunctionATP-dependent activity

ARID1A ATRX

1.30e-0261462GO:0140657
GeneOntologyMolecularFunctioncatalytic activity, acting on a nucleic acid

ARID1A ATRX

1.43e-0264562GO:0140640
GeneOntologyMolecularFunctiontranscription factor binding

ARID1A NCOA6

1.93e-0275362GO:0008134
GeneOntologyMolecularFunctionprotein domain specific binding

ATRX NCOA6

2.56e-0287562GO:0019904
GeneOntologyBiologicalProcessDNA-templated transcription initiation

ARID1A MED15 NCOA6

2.71e-0523163GO:0006352
GeneOntologyBiologicalProcessplacenta blood vessel development

ARID1A NCOA6

6.64e-054462GO:0060674
GeneOntologyBiologicalProcessnucleosome organization

ARID1A ATRX

6.93e-0414262GO:0034728
GeneOntologyBiologicalProcesstranscription initiation at RNA polymerase II promoter

ARID1A MED15

1.18e-0318662GO:0006367
GeneOntologyBiologicalProcessbrain development

ARID1A ATRX NCOA6

1.31e-0385963GO:0007420
GeneOntologyBiologicalProcessplacenta development

ARID1A NCOA6

1.33e-0319762GO:0001890
GeneOntologyBiologicalProcesshead development

ARID1A ATRX NCOA6

1.59e-0391963GO:0060322
GeneOntologyBiologicalProcessDNA damage response

ARID1A ATRX NCOA6

1.80e-0395963GO:0006974
GeneOntologyBiologicalProcessstem cell population maintenance

ARID1A MED15

1.91e-0323762GO:0019827
GeneOntologyBiologicalProcessmaintenance of cell number

ARID1A MED15

1.99e-0324262GO:0098727
GeneOntologyBiologicalProcessprotein-DNA complex organization

ARID1A MED15 ATRX

2.03e-0399963GO:0071824
GeneOntologyBiologicalProcessprotein-DNA complex assembly

MED15 ATRX

2.11e-0324962GO:0065004
GeneOntologyBiologicalProcessregulation of chromosome organization

ARID1A ATRX

2.40e-0326662GO:0033044
GeneOntologyBiologicalProcesscentral nervous system development

ARID1A ATRX NCOA6

3.41e-03119763GO:0007417
GeneOntologyBiologicalProcessepigenetic regulation of gene expression

ARID1A ATRX

3.67e-0333062GO:0040029
GeneOntologyBiologicalProcesspositive regulation of DNA metabolic process

ARID1A ATRX

3.73e-0333362GO:0051054
GeneOntologyBiologicalProcesspositive regulation of transcription by RNA polymerase II

MED15 ATRX NCOA6

5.23e-03139063GO:0045944
GeneOntologyCellularComponentnuclear protein-containing complex

ARID1A MED15 NCOA6

4.90e-03137763GO:0140513
GeneOntologyCellularComponenttranscription regulator complex

MED15 NCOA6

1.13e-0259662GO:0005667
MousePhenoabnormal spongiotrophoblast size

ARID1A NCOA6

3.85e-052852MP:0012097
MousePhenoabnormal spongiotrophoblast layer morphology

ARID1A NCOA6

2.59e-047252MP:0004255
MousePhenoabnormal placenta junctional zone morphology

ARID1A NCOA6

3.20e-048052MP:0008957
MousePhenopericardial effusion

ARID1A NCOA6

6.15e-0411152MP:0005312
MousePhenoabnormal myocardial trabeculae morphology

ARID1A NCOA6

1.03e-0314452MP:0002189
MousePhenoeffusion

ARID1A NCOA6

1.15e-0315252MP:0021205
MousePhenoembryonic lethality during organogenesis, complete penetrance

ARID1A ATRX NCOA6

1.16e-0370053MP:0011098
MousePhenoabnormal trophoblast layer morphology

ARID1A NCOA6

2.20e-0321152MP:0005031
MousePhenoembryonic lethality during organogenesis

ARID1A ATRX NCOA6

2.23e-0387653MP:0006207
MousePhenoabnormal pericardium morphology

ARID1A NCOA6

2.50e-0322552MP:0000288
PathwayWP_KLEEFSTRA_SYNDROME

ARID1A NCOA6

6.10e-052962M48076
PathwayWP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA

ARID1A ATRX

3.10e-046562M39682
PathwayREACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION

MED15 NCOA6

5.18e-048462M1008
PathwayREACTOME_ADIPOGENESIS

MED15 NCOA6

8.87e-0411062M48259
PathwayREACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA

MED15 NCOA6

1.02e-0311862M27316
PathwayREACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION

ARID1A NCOA6

4.62e-0325462M27131
PathwayREACTOME_DEVELOPMENTAL_BIOLOGY

ARID1A MED15 NCOA6

1.65e-02143263M509
Pubmed

Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.

ARID1A MED15 ACBD3 NCOA6

9.98e-074577432344865
Pubmed

The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.

ARID1A ATRX NCOA6

3.12e-061577330186101
Pubmed

Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.

ARID1A MED15 NCOA6

1.55e-052687333640491
Pubmed

Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication.

ARID1A MED15 NCOA6

1.82e-052837318854154
Pubmed

Interaction network of human early embryonic transcription factors.

ARID1A MED15 NCOA6

3.46e-053517338297188
Pubmed

Quantitative Proteomics of the SMAD (Suppressor of Mothers against Decapentaplegic) Transcription Factor Family Identifies Importin 5 as a Bone Morphogenic Protein Receptor SMAD-specific Importin.

MED15 NCOA6

3.90e-05487227703004
Pubmed

Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.

ARID1A MED15 ACBD3 NCOA6

5.28e-0512477427684187
Pubmed

Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription.

ARID1A NCOA6

5.91e-05597228813667
Pubmed

Proteomic Analysis of the EWS-Fli-1 Interactome Reveals the Role of the Lysosome in EWS-Fli-1 Turnover.

ARID1A MED15 NCOA6

6.11e-054257324999758
Pubmed

PRC1 and PRC2 are not required for targeting of H2A.Z to developmental genes in embryonic stem cells.

MED15 NCOA6

7.18e-05657222496869
Pubmed

Genetic interaction mapping in mammalian cells using CRISPR interference.

ARID1A MED15

8.09e-05697228481362
Pubmed

A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.

ARID1A ACBD3 NCOA6

8.35e-054727338943005
Pubmed

Human transcription factor protein interaction networks.

ARID1A MED15 ATRX NCOA6

8.99e-0514297435140242
Pubmed

Agonist-specific Protein Interactomes of Glucocorticoid and Androgen Receptor as Revealed by Proximity Mapping.

ARID1A NCOA6

1.04e-04787228611094
Pubmed

Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.

ARID1A NCOA6

1.17e-04837228794006
Pubmed

Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.

ARID1A MED15 ATRX

1.20e-045337330554943
Pubmed

SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.

ARID1A MED15 NCOA6

1.31e-045497338280479
Pubmed

Functional proteomics mapping of a human signaling pathway.

ATRX ACBD3 NCOA6

1.62e-045917315231748
InteractionSMAD1 interactions

ARID1A MED15 TOB1 NCOA6

7.02e-0724374int:SMAD1
InteractionSMAD2 interactions

ARID1A MED15 TOB1 NCOA6

4.39e-0638574int:SMAD2
InteractionNUP35 interactions

ARID1A MED15 ACBD3 NCOA6

6.43e-0642474int:NUP35
InteractionSMAD3 interactions

ARID1A MED15 TOB1 NCOA6

7.93e-0644774int:SMAD3
InteractionFEV interactions

ARID1A ATRX NCOA6

3.42e-0520373int:FEV
InteractionASF1A interactions

ARID1A ATRX NCOA6

6.29e-0524973int:ASF1A
InteractionHNF4A interactions

ARID1A ATRX NCOA6

8.45e-0527573int:HNF4A
InteractionTPRX2 interactions

ARID1A NCOA6

1.58e-045672int:TPRX2
InteractionAR interactions

ARID1A MED15 ATRX NCOA6

1.81e-0499274int:AR
InteractionSOX17 interactions

ARID1A NCOA6

4.55e-049572int:SOX17
InteractionSOX9 interactions

ARID1A NCOA6

4.74e-049772int:SOX9
InteractionING1 interactions

ARID1A ATRX

5.34e-0410372int:ING1
InteractionTP53BP1 interactions

ARID1A MED15 NCOA6

5.95e-0453373int:TP53BP1
InteractionTBXT interactions

ARID1A NCOA6

6.77e-0411672int:TBXT
InteractionBRD9 interactions

ARID1A ATRX

6.89e-0411772int:BRD9
InteractionTOPBP1 interactions

ARID1A ATRX

6.89e-0411772int:TOPBP1
InteractionCREBBP interactions

ARID1A ATRX NCOA6

8.36e-0459973int:CREBBP
InteractionPAX9 interactions

ARID1A NCOA6

8.49e-0413072int:PAX9
InteractionMED15 interactions

MED15 NCOA6

8.62e-0413172int:MED15
InteractionNCOA6 interactions

MED15 NCOA6

1.05e-0314572int:NCOA6
InteractionNCOA1 interactions

ARID1A NCOA6

1.07e-0314672int:NCOA1
InteractionRTF1 interactions

ARID1A MED15

1.13e-0315072int:RTF1
InteractionH3C14 interactions

ATRX NCOA6

1.22e-0315672int:H3C14
CoexpressionBRUINS_UVC_RESPONSE_EARLY_LATE

ARID1A ATRX NCOA6

3.38e-0531663M2248
CoexpressionBRUINS_UVC_RESPONSE_EARLY_LATE

ARID1A ATRX NCOA6

3.51e-0532063MM1063
CoexpressionBUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP

ACBD3 TOB1 NCOA6

5.73e-0482263M6782
CoexpressionGSE15271_CXCR4_POS_VS_NEG_GC_BCELL_DN

ARID1A TOB1

6.53e-0417562M7101
CoexpressionHE_LIM_SUN_FETAL_LUNG_C0_MID_AIRWAY_SMC_2_CELL

TOB1 NCOA6

7.61e-0418962M45678
CoexpressionGSE26488_WT_VS_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP

ACBD3 TOB1

8.10e-0419562M8194
CoexpressionGSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_DN

ARID1A NCOA6

8.26e-0419762M5877
CoexpressionGSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_DN

ATRX TOB1

8.35e-0419862M7605
CoexpressionGSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_UP

ARID1A ACBD3

8.43e-0419962M9255
CoexpressionGSE14769_40MIN_VS_360MIN_LPS_BMDM_DN

ARID1A ACBD3

8.43e-0419962M3517
CoexpressionGSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_DN

ARID1A ATRX

8.43e-0419962M7374
CoexpressionGSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_UP

ARID1A MED15

8.43e-0419962M9964
CoexpressionGSE22886_CD4_TCELL_VS_BCELL_NAIVE_UP

MED15 TOB1

8.43e-0419962M4430
CoexpressionGSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_UP

MED15 TOB1

8.43e-0419962M3217
CoexpressionGSE22886_TCELL_VS_BCELL_NAIVE_UP

MED15 TOB1

8.43e-0419962M4425
CoexpressionGSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN

ATRX TOB1

8.43e-0419962M7607
CoexpressionGSE21033_CTRL_VS_POLYIC_STIM_DC_3H_DN

TOB1 NCOA6

8.43e-0419962M7711
CoexpressionGSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_UP

ARID1A ATRX

8.52e-0420062M8050
CoexpressionGSE9037_CTRL_VS_LPS_1H_STIM_BMDM_UP

ACBD3 TOB1

8.52e-0420062M5800
CoexpressionGSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY3_POST_IMMUNIZATION_UP

ARID1A ACBD3

8.52e-0420062M9278
CoexpressionGSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_UP

ARID1A ATRX

8.52e-0420062M8090
CoexpressionGSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN

ATRX ACBD3

8.52e-0420062M6056
CoexpressionGSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN

TOB1 NCOA6

8.52e-0420062M9459
CoexpressionGSE17721_POLYIC_VS_GARDIQUIMOD_2H_BMDC_UP

ARID1A ATRX

8.52e-0420062M4018
CoexpressionGSE36009_UNSTIM_VS_LPS_STIM_DC_DN

ACBD3 TOB1

8.52e-0420062M8774
CoexpressionGSE19401_UNSTIM_VS_PAM2CSK4_STIM_FOLLICULAR_DC_DN

TOB1 NCOA6

8.52e-0420062M7671
CoexpressionGSE6674_CPG_VS_PL2_3_STIM_BCELL_DN

ACBD3 NCOA6

8.52e-0420062M6938
CoexpressionGSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_DN

ARID1A TOB1

8.52e-0420062M5837
CoexpressionGSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN

ARID1A NCOA6

8.52e-0420062M5851
CoexpressionTHEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN

ATRX TOB1

1.09e-0322762M11234
CoexpressionQI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DY_AT_1DYPOSITIVE

ARID1A NCOA6

1.83e-0329462M40873
CoexpressionAtlasDevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#1_top-relative-expression-ranked_100

ARID1A ATRX

6.86e-053972gudmap_developingGonad_e12.5_testes_k1_100
CoexpressionAtlasFacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3

ATRX ACBD3 NCOA6

8.56e-0529173Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3
CoexpressionAtlasDevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#3_top-relative-expression-ranked_100

ARID1A ATRX

1.09e-044972gudmap_developingGonad_e11.5_testes_k3_100
CoexpressionAtlasDevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_100

ARID1A ATRX

1.13e-045072gudmap_developingGonad_e11.5_testes and mesonephros_k2_100
CoexpressionAtlasFacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000

ATRX ACBD3 TOB1 NCOA6

1.44e-0498574Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000
CoexpressionAtlasDevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_100

ARID1A ATRX

3.06e-048272gudmap_developingGonad_e12.5_testes_100
CoexpressionAtlasDevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_100

ARID1A ATRX

3.44e-048772gudmap_developingGonad_e11.5_testes_100
CoexpressionAtlasDevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#5_top-relative-expression-ranked_200

ARID1A ATRX

3.52e-048872gudmap_developingGonad_e12.5_testes_k5_200
CoexpressionAtlasDevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_100

ARID1A ATRX

3.68e-049072gudmap_developingGonad_e11.5_testes and mesonephros_100
CoexpressionAtlasDevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#1_top-relative-expression-ranked_200

ARID1A ATRX

3.84e-049272gudmap_developingGonad_e11.5_testes and mesonephros_k1_200
CoexpressionAtlasDevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#5_top-relative-expression-ranked_200

ARID1A ATRX

4.45e-049972gudmap_developingGonad_e11.5_testes_k5_200
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4

ARID1A ATRX ACBD3

7.04e-0459573Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlasFacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5

ARID1A ATRX ACBD3

8.28e-0462973Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5
CoexpressionAtlasDevelopingGonad_P2_testes_emap-30171_k-means-cluster#3_top-relative-expression-ranked_500

ARID1A ATRX

8.37e-0413672gudmap_developingGonad_P2_testes_500_k3
CoexpressionAtlasDevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#1_top-relative-expression-ranked_500

ARID1A ATRX

8.87e-0414072gudmap_developingGonad_e18.5_testes_500_k1
CoexpressionAtlasDevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_200

ARID1A ATRX

1.23e-0316572gudmap_developingGonad_e12.5_testes_200
CoexpressionAtlasDevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#1_top-relative-expression-ranked_500

ARID1A ATRX

1.26e-0316772gudmap_developingGonad_e16.5_testes_500_k1
CoexpressionAtlasDevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_200

ARID1A ATRX

1.44e-0317972gudmap_developingGonad_e11.5_testes and mesonephros_200
CoexpressionAtlasDevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_200

ARID1A ATRX

1.48e-0318172gudmap_developingGonad_e11.5_testes_200
CoexpressionAtlasDevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#4_top-relative-expression-ranked_500

ARID1A ATRX

1.52e-0318472gudmap_developingGonad_e14.5_ testes_500_k4
CoexpressionAtlasFacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1

ATRX ACBD3 NCOA6

1.55e-0378073Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
CoexpressionAtlasFacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4

ATRX ACBD3

1.66e-0319272Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4
CoexpressionAtlasFacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4

ATRX ACBD3

1.85e-0320372Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4
CoexpressionAtlasDevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#2_top-relative-expression-ranked_500

ARID1A ATRX

1.85e-0320372gudmap_developingGonad_e11.5_testes_k2_500
CoexpressionAtlasDevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500

ARID1A ATRX

2.39e-0323172gudmap_developingGonad_e11.5_testes and mesonephros_k4_500
CoexpressionAtlasDevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#4_top-relative-expression-ranked_500

ARID1A ATRX

2.59e-0324172gudmap_developingGonad_e12.5_testes_k4_500
CoexpressionAtlasFacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000

ARID1A ATRX ACBD3

3.06e-0398973Facebase_RNAseq_e10.5_Maxillary Arch_1000
CoexpressionAtlasFacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4

ARID1A ATRX

3.93e-0329872Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2

ATRX NCOA6

4.28e-0331172Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
CoexpressionAtlasDevelopingGonad_P2_testes_emap-30171_k-means-cluster#2_top-relative-expression-ranked_1000

ARID1A ATRX

5.36e-0334972gudmap_developingGonad_P2_testes_1000_k2
CoexpressionAtlasDevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#3_top-relative-expression-ranked_1000

ARID1A ATRX

5.75e-0336272gudmap_developingGonad_e18.5_testes_1000_k3
CoexpressionAtlasfacebase_RNAseq_e10.5_MaxArch_2500_K3

ARID1A ATRX NCOA6

5.98e-03125273facebase_RNAseq_e10.5_MaxArch_2500_K3
CoexpressionAtlasfacebase_RNAseq_e10.5_Emin_LatNas_2500_K3

ARID1A ATRX NCOA6

6.05e-03125773facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlasDevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#3_top-relative-expression-ranked_1000

ARID1A ATRX

6.26e-0337872gudmap_developingGonad_e16.5_testes_1000_k3
CoexpressionAtlasDevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_500

ARID1A ATRX

7.19e-0340672gudmap_developingGonad_e12.5_testes_500
CoexpressionAtlasDevelopingGonad_P2_testes_emap-30171_top-relative-expression-ranked_500

ARID1A ATRX

7.26e-0340872gudmap_developingGonad_P2_testes_500
CoexpressionAtlasDevelopingGonad_e16.5_testes_emap-8444_top-relative-expression-ranked_500

ARID1A ATRX

7.29e-0340972gudmap_developingGonad_e16.5_testes_500
CoexpressionAtlasDevelopingGonad_e14.5_ testes_emap-6710_top-relative-expression-ranked_500

ARID1A ATRX

7.36e-0341172gudmap_developingGonad_e14.5_ testes_500
CoexpressionAtlasDevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_500

ARID1A ATRX

7.39e-0341272gudmap_developingGonad_e18.5_testes_500
CoexpressionAtlasDevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#5_top-relative-expression-ranked_1000

ARID1A ATRX

8.00e-0342972gudmap_developingGonad_e14.5_ testes_1000_k5
CoexpressionAtlasFacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3

ARID1A ATRX

8.10e-0343272Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3
CoexpressionAtlasDevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_500

ARID1A ATRX

8.21e-0343572gudmap_developingGonad_e11.5_testes and mesonephros_500
CoexpressionAtlasDevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_500

ARID1A ATRX

8.29e-0343772gudmap_developingGonad_e11.5_testes_500
CoexpressionAtlasfacebase_RNAseq_e10.5_Emin_LatNas_2500

ARID1A ATRX NCOA6

9.19e-03145973facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlasFacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500

ATRX ACBD3

1.04e-0249272Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500
CoexpressionAtlasDevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000

ARID1A ATRX

1.07e-0249872gudmap_developingGonad_e11.5_testes_k5_1000
CoexpressionAtlasDevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#1_top-relative-expression-ranked_1000

ARID1A ATRX

1.18e-0252472gudmap_developingGonad_e12.5_testes_k1_1000
CoexpressionAtlasDevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000

ARID1A ATRX

1.21e-0253372gudmap_developingGonad_e11.5_testes and mesonephros_k5_1000
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ATRX TOB1

3.19e-0417772426a9845df7fd13b02e744532c336c60bc4d4a22
ToppCellTCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9

ARID1A ATRX

3.79e-0419372abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCellnormal_Lung-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass

MED15 ATRX

3.87e-04195723af8ea15e2ac8efdeb4d4f69357b83b8dbcfab8d
ToppCell10x5'-Liver-Lymphocytic_T_CD8-Tem/emra_CD8|Liver / Manually curated celltypes from each tissue

MED15 TOB1

3.99e-04198722fc2a4638c458ae793ac090a29d27b75fc9e6af6
ToppCell(05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition

ATRX TOB1

4.03e-0419972d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098
ToppCell(02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition

ATRX TOB1

4.03e-041997218a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCell(04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition

ATRX TOB1

4.03e-041997253ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell(00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition

ATRX TOB1

4.03e-041997219674e1eaeb51e4196d847cb62aa437c852951d3
ToppCell(09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition

ATRX TOB1

4.03e-0419972fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells-Neuroepithelial_cell|GW13 / Sample Type, Dataset, Time_group, and Cell type.

ARID1A MED15

4.07e-04200723d932765c31aef1f80a118d51e8e66c50a758dbb
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type.

ARID1A MED15

4.07e-0420072d933978b55fefe52cad599b36f6b47a0c7f71f96
ComputationalGenes in the cancer module 243.

ACBD3 TOB1

8.25e-048162MODULE_243
Drugfisetin; Down 200; 50uM; PC3; HG-U133A

ARID1A ACBD3 NCOA6

9.24e-0617863579_DN
Drugemtricitabine

TOB1 NCOA6

6.11e-0414762CID000060877
DrugTrichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA

ARID1A NCOA6

8.15e-04170621050_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA

ARID1A NCOA6

8.34e-04172621072_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

ARID1A MED15

8.34e-04172624112_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A

ARID1A NCOA6

8.54e-04174621659_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA

ARID1A NCOA6

8.63e-04175621014_DN
DrugSAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA

ARID1A NCOA6

8.63e-04175621058_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

ARID1A MED15

8.73e-04176622639_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

ARID1A NCOA6

8.73e-04176626932_DN
DrugSAHA; Down 200; 10uM; MCF7; HT_HG-U133A

ARID1A NCOA6

8.83e-04177621645_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

ARID1A NCOA6

8.83e-04177626972_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

ARID1A NCOA6

8.93e-04178627245_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA

ARID1A NCOA6

8.93e-04178621112_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

ARID1A MED15

9.13e-04180624821_DN
DrugLY 294002; Up 200; 10uM; PC3; HT_HG-U133A

ARID1A ATRX

9.23e-04181621236_UP
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A

ARID1A NCOA6

9.33e-04182621891_DN
DrugGW8510; Down 200; 10uM; PC3; HT_HG-U133A

ARID1A TOB1

9.33e-04182627085_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

ARID1A ATRX

9.33e-04182625802_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A

ARID1A NCOA6

9.33e-04182621951_DN
DrugDoxorubicin hydrochloride [25316-40-9]; Down 200; 6.8uM; PC3; HT_HG-U133A

ARID1A TOB1

9.54e-04184624610_DN
DrugDoxorubicin hydrochloride [25316-40-9]; Down 200; 6.8uM; MCF7; HT_HG-U133A

ARID1A TOB1

9.54e-04184625671_DN
DrugMonensin sodium salt [22373-78-0]; Up 200; 5.8uM; PC3; HT_HG-U133A

ARID1A ACBD3

9.64e-04185627402_UP
DrugH-7 dihydrochloride; Down 200; 100uM; MCF7; HT_HG-U133A

ARID1A TOB1

1.01e-03189625936_DN
Drugcarbamazepine; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA

ARID1A MED15

1.01e-0318962835_UP
Drugrottlerin; Up 200; 10uM; MCF7; HT_HG-U133A_EA

MED15 ATRX

1.02e-0319062914_UP
DrugQuinacrine dihydrochloride dihydrate [6151-30-0]; Up 200; 7.8uM; HL60; HG-U133A

ARID1A TOB1

1.03e-03191621563_UP
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A

ARID1A NCOA6

1.03e-03191627503_DN
DrugDizocilpine maleate [77086-22-7]; Up 200; 11.8uM; MCF7; HT_HG-U133A

ARID1A MED15

1.05e-03193626223_UP
DrugPentetic acid [67-43-6]; Down 200; 10.2uM; MCF7; HT_HG-U133A

ARID1A ATRX

1.05e-03193625629_DN
DrugCeforanide [60925-61-3]; Down 200; 7.6uM; PC3; HT_HG-U133A

ARID1A MED15

1.05e-03193626751_DN
DrugProgesterone [57-83-0]; Down 200; 12.8uM; PC3; HT_HG-U133A

ARID1A MED15

1.05e-03193626646_DN
DrugEucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A

ATRX ACBD3

1.05e-03193623841_DN
DrugTrazodone hydrochloride [25332-39-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A

ARID1A MED15

1.06e-03194627410_UP
Drug2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A_EA

ARID1A MED15

1.06e-03194621060_UP
DrugBrinzolamide [138890-62-7]; Down 200; 10.4uM; PC3; HT_HG-U133A

ARID1A MED15

1.07e-03195626670_DN
DrugRaloxifene hydrochloride [82640-04-8]; Up 200; 7.8uM; MCF7; HT_HG-U133A

ARID1A MED15

1.07e-03195626235_UP
DrugMetolazone [17560-51-9]; Down 200; 11uM; MCF7; HT_HG-U133A

ARID1A ATRX

1.07e-03195621514_DN
DrugButamben [94-25-7]; Down 200; 20.6uM; MCF7; HT_HG-U133A

ARID1A MED15

1.07e-03195626266_DN
DrugTestosterone propionate [57-85-2]; Down 200; 11.6uM; PC3; HT_HG-U133A

ARID1A ATRX

1.07e-03195624676_DN
DrugMethoxy-8-psoralen [298-81-7]; Down 200; 18.6uM; PC3; HT_HG-U133A

ARID1A MED15

1.07e-03195626661_DN
DrugEthionamide [536-33-4]; Down 200; 24uM; MCF7; HT_HG-U133A

ARID1A MED15

1.07e-03195624418_DN
DrugCarbamazepine [298-46-4]; Down 200; 17uM; PC3; HT_HG-U133A

ARID1A ATRX

1.07e-03195625093_DN
DrugSulfaquinoxaline sodium salt [967-80-6]; Up 200; 12.4uM; HL60; HT_HG-U133A

ARID1A ATRX

1.08e-03196622528_UP
DrugBretylium tosylate [61-75-6]; Down 200; 9.6uM; MCF7; HT_HG-U133A

ARID1A MED15

1.08e-03196625020_DN
Drugikarugamycin; Up 200; 2uM; MCF7; HT_HG-U133A_EA

ARID1A MED15

1.08e-0319662918_UP
DrugAzaperone [1649-18-9]; Down 200; 12.2uM; PC3; HT_HG-U133A

ARID1A ATRX

1.08e-03196625877_DN
Drug(+/-)-verapamil hydrochloride; Down 200; 10uM; MCF7; HG-U133A

ARID1A ACBD3

1.09e-0319762161_DN
DrugDiazoxide [364-98-7]; Down 200; 17.4uM; HL60; HG-U133A

MED15 ACBD3

1.09e-03197621368_DN
DrugClopamide [636-54-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A

MED15 ATRX

1.09e-03197623220_DN
DrugTolnaftate [2398-96-1]; Up 200; 13uM; PC3; HG-U133A

ARID1A MED15

1.09e-03197621919_UP
DrugLevopropoxyphene napsylate [5714-90-9]; Down 200; 7.4uM; PC3; HT_HG-U133A

ARID1A MED15

1.10e-03198625083_DN
DrugAmitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; MCF7; HT_HG-U133A

MED15 ATRX

1.10e-03198621701_DN
DrugKetoprofen [22071-15-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A

MED15 ATRX

1.10e-03198622316_DN
DrugTocainide hydrochloride; Down 200; 17.4uM; MCF7; HT_HG-U133A

ARID1A MED15

1.10e-03198624838_DN
DrugStreptozotocin [18883-66-4]; Down 200; 15uM; MCF7; HT_HG-U133A

ARID1A MED15

1.10e-03198627193_DN
DrugHyoscyamine (L) [101-31-5]; Down 200; 13.8uM; PC3; HT_HG-U133A

ARID1A MED15

1.10e-03198625099_DN
DrugMeclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A

MED15 ATRX

1.10e-03198624729_DN
DrugDiethylcarbamazine citrate [1642-54-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A

MED15 ATRX

1.10e-03198625485_DN
DrugRiluzole hydrochloride; Down 200; 14.8uM; PC3; HT_HG-U133A

ARID1A ATRX

1.10e-03198623666_DN
Drugcolcemid; Down 200; 11.7uM; MCF7; HT_HG-U133A_EA

ATRX ACBD3

1.10e-03198621103_DN
DrugKetotifen fumarate [34580-14-8]; Down 200; 9.4uM; MCF7; HT_HG-U133A

ARID1A MED15

1.10e-03198627199_DN
DrugThioproperazine dimesylate [2347-80-0]; Down 200; 6.2uM; MCF7; HT_HG-U133A

ARID1A MED15

1.11e-03199626265_DN
DrugDecamethonium bromide [541-22-0]; Down 200; 9.6uM; HL60; HT_HG-U133A

ARID1A MED15

1.11e-03199622933_DN
DrugFlurbiprofen [5104-49-4]; Up 200; 16.4uM; MCF7; HT_HG-U133A

ARID1A ATRX

1.11e-03199625269_UP
DrugTiletamine hydrochloride; Down 200; 15.4uM; PC3; HT_HG-U133A

MED15 ATRX

1.11e-03199627311_DN
DrugMetixene hydrochloride [1553-34-0]; Down 200; 11.6uM; PC3; HT_HG-U133A

ARID1A MED15

1.11e-03199626672_DN
DrugBergenin monohydrate [477-90-7]; Down 200; 11.6uM; PC3; HT_HG-U133A

MED15 ATRX

1.11e-03199625870_DN
DrugMerbromin [129-16-8]; Down 200; 5uM; PC3; HT_HG-U133A

MED15 ATRX

1.11e-03199627398_DN
Drugthalidomide

TOB1 NCOA6

1.47e-0322962CID000005426
Diseasecolon cancer (is_implicated_in)

ARID1A NCOA6

3.03e-053672DOID:219 (is_implicated_in)
DiseaseNeuroblastoma

ARID1A ATRX

5.19e-054772C0027819
DiseaseAdenoid Cystic Carcinoma

ARID1A ATRX

2.36e-0410072C0010606
Diseasebreast cancer (is_implicated_in)

ARID1A NCOA6

5.30e-0415072DOID:1612 (is_implicated_in)
DiseaseEndometriosis

TOB1 NCOA6

6.10e-0416172C0014175
DiseaseEndometrioma

TOB1 NCOA6

6.10e-0416172C0269102
Diseasetestosterone measurement

C18orf63 ARID1A NCOA6

2.47e-03127573EFO_0004908
Diseaseforced expiratory volume

MED15 NCOA6

1.37e-0278972EFO_0004314

Protein segments in the cluster

PeptideGeneStartEntry
SQQTTMYQQQQQNYK

ARID1A

1356

O14497
QQQFQAQQSAMQQQF

MED15

186

Q96RN5
QQYMQQLYQVQLAQQ

ACBD3

286

Q9H3P7
MQGNKQQFNTQNQSN

NCOA6

721

Q14686
QQYNQQQQQQMTYQQ

ATRX

2416

P46100
YSSNIQMQAANNLNQ

C18orf63

491

Q68DL7
NFSLNNMQYSNQQFQ

TOB1

326

P50616